| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,179 |
7,415 |
$585K |
| 96367 |
|
18,778 |
4,791 |
$326K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14,039 |
4,610 |
$306K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,980 |
3,685 |
$262K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
22,531 |
6,644 |
$240K |
| 99233 |
Prolong inpt eval add15 m |
9,926 |
1,168 |
$159K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,487 |
1,868 |
$81K |
| 99215 |
Prolong outpt/office vis |
1,593 |
1,358 |
$74K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
24,418 |
6,847 |
$57K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,746 |
7,757 |
$47K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,870 |
5,102 |
$45K |
| 99000 |
|
8,783 |
3,658 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,687 |
672 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,588 |
2,193 |
$23K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,115 |
808 |
$22K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14,030 |
6,771 |
$22K |
| 96415 |
|
717 |
389 |
$12K |
| 80076 |
|
10,949 |
6,311 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,671 |
1,706 |
$11K |
| J3490 |
Unclassified drugs |
10,047 |
2,721 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,675 |
595 |
$6K |
| 96417 |
|
264 |
144 |
$4K |
| 82378 |
|
1,640 |
1,561 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
849 |
837 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
313 |
287 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
7,372 |
3,624 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,369 |
1,340 |
$3K |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
5,847 |
3,039 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
124 |
66 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
80 |
24 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
99 |
75 |
$1K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
6,652 |
3,473 |
$840.21 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
77 |
42 |
$837.38 |
| 80061 |
Lipid panel |
445 |
437 |
$784.17 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,843 |
3,013 |
$698.06 |
| 1036F |
|
3,534 |
1,780 |
$648.47 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
121 |
52 |
$645.34 |
| 99205 |
Prolong outpt/office vis |
14 |
14 |
$642.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
4,247 |
2,233 |
$568.78 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
88 |
26 |
$409.51 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
2,559 |
1,475 |
$355.56 |
| G9991 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
839 |
454 |
$350.76 |
| 84153 |
|
216 |
205 |
$311.02 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
166 |
147 |
$216.59 |
| 3017F |
|
659 |
386 |
$131.36 |
| 1123F |
|
1,073 |
599 |
$37.14 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,289 |
704 |
$27.63 |
| 84403 |
|
14 |
14 |
$25.81 |
| G8482 |
Influenza immunization administered or previously received |
416 |
271 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
981 |
556 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
165 |
84 |
$0.00 |
| 4040F |
|
222 |
147 |
$0.00 |
| 1124F |
|
14 |
14 |
$0.00 |